Xxxxx Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study, and Principal Investigator has agreed to share this summary with Institution in order to communicate the results, as appropriate, to the Study Subjects. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with the ŠÚKL/IEC as appropriate, will cooperate with Principal Investigator or Institution to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institution.
Appears in 1 contract
Samples: Clinical Study Agreement
Xxxxx Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study, and Principal Investigator has agreed to share this summary with Institution in order to communicate the results, as appropriate, to the Study SubjectsInstitution. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with the ŠÚKL/IEC as appropriate, will cooperate with Principal Investigator or Institution to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institution.appropriately
Appears in 1 contract
Samples: Clinical Study Agreement
Xxxxx Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study, and Principal Investigator has agreed to share this summary with Institution in order to communicate the results, as appropriate, to the Study SubjectsInstitution. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with the ŠÚKL/IEC as appropriate, will cooperate with Principal Investigator or Institution to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institution. skúšania do dvoch rokov po ukončení klinického skúšania.
Appears in 1 contract
Samples: Clinical Study Agreement
Xxxxx Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study, and Principal Investigator has agreed to share this summary with Institution in order to communicate the results, as appropriate, to the Study SubjectsInstitution. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with the ŠÚKL/IEC as appropriate, will cooperate with Principal Investigator or Institution to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institution.
Appears in 1 contract
Samples: Clinical Study Agreement